Chemoinformaics analysis of CINCHOTANNIC-ACID
| Molecular Weight | 311.29 | nRot | 4 |
| Heavy Atom Molecular Weight | 294.154 | nRig | 9 |
| Exact Molecular Weight | 311.1 | nRing | 1 |
| Solubility: LogS | -1.198 | nHRing | 0 |
| Solubility: LogP | 0.234 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 39 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 1 |
| nHetero | 8 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 17 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 14 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 6 |
| nHA | 5 | APOL | 41.4295 |
| nHD | 4 | BPOL | 21.9645 |
| QED | 0.778 |
| Synth | 2.528 |
| Natural Product Likeliness | 0.539 |
| NR-PPAR-gamma | 0.265 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.008 |
| HIA | 0.113 |
| CACO-2 | -5.41 |
| MDCK | 0.00000999 |
| BBB | 0.175 |
| PPB | 0.566245 |
| VDSS | 0.269 |
| FU | 0.402127 |
| CYP1A2-inh | 0.037 |
| CYP1A2-sub | 0.233 |
| CYP2c19-inh | 0.033 |
| CYP2c19-sub | 0.059 |
| CYP2c9-inh | 0.031 |
| CYP2c9-sub | 0.37 |
| CYP2d6-inh | 0.022 |
| CYP2d6-sub | 0.241 |
| CYP3a4-inh | 0.012 |
| CYP3a4-sub | 0.204 |
| CL | 4.838 |
| T12 | 0.933 |
| hERG | 0.011 |
| Ames | 0.062 |
| ROA | 0.029 |
| SkinSen | 0.183 |
| Carcinogencity | 0.149 |
| EI | 0.093 |
| Respiratory | 0.022 |
| NR-Aromatase | 0.01 |
| Antiviral | Yes |
| Prediction | 0.667141 |